Experiments
Searchable full-text extractions: founding hypothesis, core claims, experimental setups, key results and statistics — pulled out of each paper as structure. Search a cell line, an assay or an entity (e.g. HUH7) and find every paper that worked with it. This corpus stands on its own: most entries carry no reproduction assessment (yet).
-
Has reproduction
Fast, accurate, and racially unbiased pan-cancer tumor-only variant calling with tabular machine learning.
PMID 36611079 · PMC9825621 · NPJ precision oncology · 2023 · 8 claims · 8 setups
Tree-based (XGBoost, LightGBM) and deep-learning (TabNet) tabular ML classifiers achieve state-of-the-art somatic vs germline classification in tumor-only WES samples, outperforming PureCN.
-
Full-text index only
A differential single-cell transcriptome atlas of left-sided and right-sided colorectal cancer.
PMID 41844817 · PMC13111741 · Discover oncology · 2026 · 8 claims · 8 setups
MTRNR2L8 is markedly upregulated in RCRC tumor cells and is associated with poorer patient survival
-
Full-text index only
DupyliCate: mining, classifying, and characterizing gene duplications.
PMID 42209743 · PMC13219399 · Scientific reports · 2026 · 8 claims · 8 setups
DupyliCate is a Python tool for identifying and classifying gene duplication arrays, using BUSCO-based species-specific thresholds and offering integrated expression divergence and Ka/Ks analysis.
-
Full-text index only
Highlights of international conference of immunogenomics and immunomics, October 8-12, 2006 Budapest, Hungary.
PMID 17470366 · PMC7130317 · Cellular immunology · 2006 · 8 claims · 8 setups
An 'immunological constant of rejection' involving interferon-stimulated genes (ISGs) and innate immune effector functions (IEF) underlies diverse immune-mediated tissue destruction processes (allograft rejection, cancer rejection, autoimmunity, infection)
-
Full-text index only
Synthetic super-enhancers enable precision viral immunotherapy.
PMID 41951744 · PMC13149004 · Nature · 2026 · 8 claims · 8 setups
Synthetic super-enhancers (SSEs) assembled from validated 160 bp SOX2/SOX9-bound enhancer fragments achieve strong and highly selective transcriptional activity in glioblastoma stem cells (GSCs)